Enlivex Announces Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Alone and in Combination with a PD1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors
Multi-center trial of AllocetraTM in advanced solid tumor patients AllocetraTM is administered to the patients either intravenously or locally, depending…